Death toll from Taliban blast in Afghan capital reaches 16, with 119 wounded says official
Jeck Deocampo • September 3, 2019	• 1053
A Taliban vehicle bomb exploded late on Monday (September 2) close to a housing compound used by international organizations in the Afghan capital Kabul, killing at least 16 people and wounding 119, officials said.
The blast, which shook buildings several kilometres away, came just as Zalmay Khalilzad, the special U.S. envoy for peace in Afghanistan was outlining details of a draft accord with the insurgent movement in a television interview.
Following major Taliban attacks on two northern cities over the weekend, the bombing in a heavily populated area of the capital added to questions around the peace deal reached between U.S. and Taliban negotiators.
The Interior Ministry said the blast was caused by a tractor packed with explosives close to Green Village, a residential compound in eastern Kabul used by foreign staff of international groups including aid organizations. (REUTERS)
(Production: Samargul Zwak, Aziz Mohammad, Sayed Hassib)
TAGS Afghan, Afghan capital Kabul, Afghanistan, death toll, Taliban
Reported deaths due to Typhoon Odette climbs to 400 – NDRRMC
Robie de Guzman • December 31, 2021
MANILA, Philippines – The number of reported deaths due to the onslaught of Typhoon Odette has exceeded 400, the National Disaster Reduction and Management Council (NDRRMC) said Friday.
In its latest report, the NDRRMC recorded 405 fatalities, while 82 persons were reported missing and 1,147 were injured.
The typhoon affected a total of 4,457,846 individuals or 1,139,148 families in 11 regions.
Areas affected include Palawan, Negros Occidental, Bohol, Cebu, Negros Oriental, Southern Leyte, Leyte, Dinagat Islands, and Surigao del Norte.
A total of 532,096 houses were damaged during the typhoon with an estimated cost of P28,163,718, the NDRRMC said.
The damage to infrastructure was pegged at ₱ 16,715,368,482.11 while the cost of damage to agriculture was estimated at P6,683,206,250.24.
The NDRRMC also noted that the power supply has been restored in 205 out of 284 cities and municipalities that experienced power outages following the typhoon’s onslaught.
Seventeen areas in MIMAROPA, Region 10, CARAGA, and CARAGA are still without water supply.
Meanwhile, telecommunication services have been restored in 79 out of 165 cities and municipalities affected by the calamity, the NDRRMC said.
TAGS death toll, NDRRMC, Typhoon Odette
Reported deaths due to Odette nears 400 – NDRRMC
MANILA, Philippines – Nearly 400 people were reported killed due to the onslaught of Typhoon Odette, latest data from the National Disaster Risk Reduction and Management Council (NDRRMC) showed.
In an update released on Tuesday, the NDRRMC said the death toll has climbed to 397.
The number of missing persons also rose to 83 from Monday’s 64 while a total of 1,147 people have been reported injured.
The typhoon affected a total of 4,235,400 persons or 1,082,910 families in 11 regions.
The NDRRMC also reported a total of 508,785 damaged houses due to Odette, with an estimated cost of P28,163,718.
Around 325 infrastructures were also damaged due to the typhoon, amounting to P16,715,334,982.11.
The typhoon’s estimated cost of damage to agriculture was at P5,342,538,557.25.
The agency said that power supply has been restored in 161 out of 284 areas that experienced power outage in MIMAROPA, Region 6, Region 7, Region 8, Region 9, Region 10, Region 11, CARAGA, and Bangsamoro region.
A total of 18 cities/ municipalities are still without water supply while 371 areas faced issues in telecommunications.
TAGS death toll, NDRRMC, ODETTE, Philippines
Reported deaths due to Odette climb to 326, 58 missing – NDRRMC
MANILA, Philippines — The number of reported deaths due to Typhoon Odette has reached 326, the latest data from the National Disaster Risk Reduction and Management Council (NDRRMC) showed.
In its report released on Friday, a total of 58 people were reported missing, while 661 others were injured due to the onslaught of Odette in many areas in the Visayas and Mindanao.
A total of 3,380,167 persons or 870,334 families from 5,508 barangays in 11 regions were affected by the calamity, it added.
Affected regions include MIMAROPA, Bicol, Western Visayas, Central Visayas, Eastern Visayas, Zamboanga, Northern Mindanao, Davao, Soccsksargen, CARAGA, and Bangsamoro.
Electricity has been restored in 149 out of 273 cities and municipalities that experienced power outages following the storm, the NDRRMC said.
Three cities and municipalities are still without access to water while 371 areas are still experiencing communication problems.
The NDRRMC noted that Odette damaged a total of 348,642 houses, around P3.9 billion worth of infrastructures, and more than P2 billion worth of crops, livestock, and fisheries.
A total of 126 ports were reported non-operational or had suspended trips. Of which, 72 ports resumed operations in CALABARZON, MIMAROPA, Region 5, Region 7, Region 9, Region 10, the NDRRMC said.
At least 1,353 passengers, 697 rolling cargoes, and 4 vessels were stranded.
A total of 343 cities/municipalities were declared under a state of calamity, the NDRRMC said.
TAGS death toll, Mindanao, ODETTE, Philippines, Typhoon Odette, Visayas


iamjwal.com
Par 3 Near Me
Cheap Sneakers
CH14 – Forging the National Economy
Time Frame: 1790-1860
Objectives: At the end of this chapter, you should be able to:
Describe the growth and movement of America’s population in the early nineteenth century.
Describe the largely German and Irish wave of immigration beginning in the 1830s and the reactions it provoked among native Americans.
Explain why America was relatively slow to embrace the industrial revolution and the factory.
Describe the early development of the factory system and Eli Whitney’s system of interchangeable parts.
Outline early industrialism’s effects on workers, including women and children.
Describe the impact of new technologies, including transportation and communication systems, on American business and agriculture.
Describe the development of a continental market economy and its revolutionary effects on both producers and consumers.
Explain why the emerging industrial economy could raise the general level of prosperity, while simultaneously creating greater disparities of wealth between rich and poor.
© 2021 iamjwal.com. All rights reserved, unless otherwise noted.


Government Information Specialist
The Department of Homeland Security (DHS) is calling on those who want to help protect American interests and secure our Nation. DHS Components work collectively to prevent terrorism; secure borders and our transportation systems; protect the President and other dignitaries; enforce and administer immigration laws; safeguard cyberspace; and ensure resilience to disasters. We achieve these vital missions through a diverse workforce spanning hundreds of occupations. Make an impact; join DHS.
When disaster strikes, America looks to the Federal Emergency Management Agency (FEMA). Now FEMA looks to you. Join our team and use your talent to support Americans in their times of greatest need. FEMA prepares the nation for all hazards and manages Federal response and recovery efforts following any national incident. We foster innovation, reward performance and creativity, and provide challenges on a routine basis with a well-skilled, knowledgeable, high performance workforce. Please visit www.fema.gov for additional information.
EMERGENCY ASSIGNMENT: Every FEMA employee has regular and recurring emergency management responsibilities, though not every position requires routine deployment to disaster sites. All positions are subject to recall around the clock for emergency management operations, which may require irregular work hours, work at locations other than the official duty station, and may include duties other than those specified in the employee's official position description. Travel requirements in support of emergency operations may be extensive in nature (weeks to months), with little advance notice, and may require employees to relocate to emergency sites with physically austere and operationally challenging conditions.
This position is located in the Federal Emergency Management Agency (FEMA), Mission Support (MS), Office of the Chief Administrative Officer (OCAO), Information Management Division (IMD), Privacy Branch (PB). Typical assignments include:
Developing Privacy Threshold Analysis (PTAs), Privacy Impact Assessments (PIAs), System of Records Notices (SORNs), Notices of Proposed Rulemakings (NPRMs), Final Rules, Privacy Act Section e (3) Statements, Information Sharing Access Agreement (ISAs), and Computer Matching Agreements;
Conducting site inspections and privacy compliance reviews;
Providing in-depth privacy training, education programs and awareness forums for FEMA stakeholders and external partners;
Serving as the point of contact within FEMA for guidance and interpretation of Privacy and FOIA, and recommending ways for improving effectiveness and efficiency across FEMA; and
Consulting and coordinating with FEMA program offices and other agencies on unprecedented procedural problems regarding privacy, disclosure, or records management to ensure government-wide consistency in handling of same.
Promotion Potential: Future promotions will be dependent on your ability to perform the duties at a higher level, the continuing need for an employee assigned to the higher level, and administrative approval.
You must be a U.S. citizen to apply for this position.
You must successfully pass a background investigation.
Selective Service registration required.
Current federal employees must meet time-in-grade requirements.
You must be able to obtain and maintain a Government credit card.
Please review "Other Information" section for additional key requirements.
To ensure the accomplishment of our mission, DHS requires every employee to be reliable and trustworthy. To meet those standards, all selected applicants must undergo, successfully pass, and maintain a background investigation for Public Trust/Moderate Risk as a condition of placement into this position. This may include a credit check after initial job qualifications are determined, a review of financial issues, such as delinquency in the payment of debts, child support and/or tax obligations, as well as certain criminal offenses and illegal use or possession of drugs (please visit: Mythbuster on Federal Hiring Policies for additional information ). For more information on background investigations for Federal jobs please visit OPM Investigations .
COVID VACCINATION: As required by Executive Order 14043, Federal employees are required to be fully vaccinated against COVID-19 regardless of the employee's duty location or work arrangement (e.g., telework, remote work, etc.), subject to such exceptions as required by law. If selected, you will be required to be vaccinated against COVID-19 and submit documentation of proof of vaccination by November 22, 2021 or before appointment or onboarding with the agency, if after November 22. The agency will provide additional information regarding what information or documentation will be needed and how you can request of the agency a legally required exception from this requirement.
Due to COVID-19, FEMA is currently in an expanded telework posture which will end January 31, 2022. Therefore, if selected, you may be expected to temporarily telework, even if your home is located outside the local commuting area. Once employees are permitted to return to the office, you will be expected to report to the duty station listed on this announcement. At that time, you may be eligible to request to continue to telework one or more days a pay period in accordance with FEMA's telework policy.
Please ensure you meet the qualification requirements described below.
Current Federal employees must have served 52 weeks at the next lower grade or equivalent grade band in the Federal service. The time-in-grade requirement must be met within 30 days of the closing date of this announcement.
The qualification requirements listed below must be met within 30 days of the closing date of the announcement.
You qualify for this position at the GS-11 level (starting salary $72,750) if you possess the following: One full year of specialized experience equivalent to the next lower grade (GS-09) in the Federal Service. This experience may have been gained in the federal government, a state or local government, a non-profit organization, the private sector, or as a volunteer; however, your resume must clearly describe at least one year of specialized experience. Specialized experience for this position includes:
Preparing documentation for, and drafting responses to general inquiries; and
Assisting in the development of Privacy Threshold Assessments, Privacy Impact Assessments (PIA) and System of Records Notices (SORN);
Educational Substitution - a Ph.D. or equivalent doctoral degree OR three full years of progressively higher level graduate education leading to such a degree, OR LL.M. if related;
a Combination of education and experience.
Experience refers to paid and unpaid experience, including volunteer work done through National Service programs (e.g. Peace Corps, AmeriCorps) and other organizations (e.g., professional; philanthropic; religious; spiritual; community, student, social). Volunteer work helps build critical competencies, knowledge, and skills, and provides valuable training and experience that translates directly to paid employment. You will receive credit for all qualifying experience, including volunteer experience.
NOTE: Qualifications are based on breadth/level of experience. In addition to describing duties performed, applicants must provide the exact dates of each period of employment (from MM/YY to MM/YY) and the number of hours worked per week if part time. As qualification determinations cannot be made when resumes do not include the required information, failure to provide this information may result in disqualification. Applicants are encouraged to use the USAJOBS Resume Builder to develop their federal resume. For a brief video on How to Create a Federal Resume, click here .
Current or former FEMA Reservists/DAE employees: To accurately credit your experience for these intermittent positions, make sure to list the dates (from MM/YY to MM/YY) of each deployment, along with the job title and specific duties you were responsible for during each deployment. Failure to provide this information may result in disqualification.
The Office of Personnel Management (OPM) must authorize employment offers made to current or former political appointees. If you are currently, or have been within the last 5 years, a political Schedule A, Schedule C, Non-career SES or Presidential Appointee employee in the Executive Branch, you must disclose this information to the Human Resources Office.
If you are qualifying based on education submit a copy of your college transcript (unofficial is acceptable) from an accredited institution. Once selected and prior to appointment, applicants must provide an official college transcript. Education completed in foreign colleges or universities may be used to meet Federal qualification requirements if you can show that your foreign education is comparable to education received in accredited educational institutions in the United States. For example, specific courses accepted for college-level credit by an accredited U.S. college or university, or foreign education evaluated by an organization recognized for accreditation by the Department of Education as education equivalent to that gained in an accredited U.S. college or university. It is your responsibility to provide such evidence with your application. See Recognition of Foreign Qualifications for more information.
If you receive a conditional offer of employment for this position, you will be required to complete an Optional Form 306, Declaration for Federal Employment , and to sign and certify the accuracy of all information in your application, prior to entry on duty. False statements on any part of the application may result in withdrawal of offer of employment, dismissal after beginning work, fine, or imprisonment.
DHS uses E-verify, an internet based system, to confirm the eligibility of all newly hired employees to work in the United States. Learn more about E-Verify , including your rights and responsibilities.
The Department of Homeland Security encourages persons with disabilities to apply, to include persons with intellectual, severe physical or psychiatric disabilities, as defined by 5 CFR § 213.3102(u), and/or Disabled Veterans with a compensable service-connected disability of 30 percent or more as defined by 5 CFR § 315.707. Veterans , Peace Corps / VISTA volunteers , and persons with disabilities possess a wealth of unique talents, experiences, and competencies that can be invaluable to the DHS mission. If you are a member of one of these groups, you may not have to compete with the public for federal jobs. To determine your eligibility for non-competitive appointment and to understand the required documentation, click on the links above or contact the Servicing Human Resources Office listed at the bottom of this announcement.
This announcement may be used to fill one or more vacancies.
All candidates must be able to deploy with little or no advance notice to anywhere in the United States and its territories for an extended period of time.
A one year probationary period is required for new Federal competitive service employees and new supervisors and managers.
If selected for this position, and you have not previously completed these requirements, you are subject to (1) completion of a 2 day onboarding program at your primary duty location; and, (2) completion of a subsequent, multiple day orientation program within 90-120 days of hire, at a location to be determined. Travel associated with the orientation portion of this requirement may be at FEMA's expense.
This is a Bargaining Unit position.
Due weight will be given to performance appraisals and incentive awards in merit promotion selection decisions in accordance with 5 CFR 335.103(b)(3).
Applying to this announcement certifies that you give permission for DHS to share your application with others in DHS for similar positions.
Supervisory Government Information Specialist
Save Supervisory Government Information Specialist
Save Government Information Specialist
Administrative Federal jobs in Washington D.C.


Justia Regulation Tracker Department Of Justice Drug Enforcement Administration Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines Into Schedule I, 61991-61993 [2013-24432]
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines Into Schedule I, 61991-61993 [2013-24432]
Download as PDF 61991 Proposed Rules Federal Register Vol. 78, No. 197 Thursday, October 10, 2013 This section of the FEDERAL REGISTER contains notices to the public of the proposed issuance of rules and regulations. The purpose of these notices is to give interested persons an opportunity to participate in the rule making prior to the adoption of the final rules. DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Part 1308 [Docket No. DEA–382] Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines Into Schedule I Drug Enforcement Administration, Department of Justice. ACTION: Notice of Intent. AGENCY: The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to temporarily schedule three synthetic phenethylamines into the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 2-(4iodo-2,5-dimethoxyphenyl)-N-(2methoxybenzyl)ethanamine (25INBOMe; 2C-I-NBOMe; 25I; Cimbi-5), 2(4-chloro-2,5-dimethoxyphenyl)-N-(2methoxybenzyl)ethanamine (25CNBOMe; 2C-C-NBOMe; 25C; Cimbi-82), and 2-(4-bromo-2,5-dimethoxyphenyl)N-(2-methoxybenzyl)ethanamine (25BNBOMe; 2C-B-NBOMe; 25B; Cimbi-36) [hereinafter 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe]. This action is based on a finding by the Deputy Administrator that the placement of these synthetic phenethylamines into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. Any final order will be published in the Federal Register and may not be issued prior to November 12, 2013. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to Schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research, and conduct of instructional activities of these synthetic phenethylamines. FOR FURTHER INFORMATION CONTACT: Ruth A. Carter, Chief, Policy Evaluation pmangrum on DSK3VPTVN1PROD with PROPOSALS SUMMARY: VerDate Mar<15>2010 12:03 Oct 09, 2013 Jkt 232001 and Analysis Section, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152, Telephone (202) 598–6812. SUPPLEMENTARY INFORMATION: Background Section 201 of the CSA, 21 U.S.C. 811, provides the Attorney General with the authority to temporarily place a substance into Schedule I of the CSA for two years without regard to the requirements of 21 U.S.C. 811(b) if he finds that such action is necessary to avoid imminent hazard to the public safety. 21 U.S.C. 811(h). In addition, if proceedings to control a substance are initiated under 21 U.S.C. 811(a)(1), the Attorney General may extend the temporary scheduling for up to one year. 21 U.S.C. 811(h)(2). Where the necessary findings are made, a substance may be temporarily scheduled if it is not listed in any other schedule under section 202 of the CSA, 21 U.S.C. 812, or if there is no exemption or approval in effect under section 505 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355, for the substance. 21 U.S.C. 811(h)(1). The Attorney General has delegated his authority under 21 U.S.C. 811 to the Administrator of the DEA, who in turn has delegated her authority to the Deputy Administrator of the DEA. 28 CFR 0.100, 0.104. Section 201(h)(4) of the CSA, 21 U.S.C. 811(h)(4), requires the Deputy Administrator to notify the Secretary of the Department of Health and Human Services (HHS) of his intention to temporarily place a substance into Schedule I of the CSA.1 As 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe are not currently listed in any schedule under the CSA, the DEA believes that the conditions of 21 U.S.C. 811(h)(1) have been satisfied. Any comments submitted by the Assistant Secretary in response to 1 Because the Secretary of the HHS has delegated to the Assistant Secretary for Health of the HHS the authority to make domestic drug scheduling recommendations, for purposes of this Notice of Intent, all subsequent references to ‘‘Secretary’’ have been replaced with ‘‘Assistant Secretary.’’ As set forth in a memorandum of understanding entered into by HHS, the Food and Drug Administration (FDA), and the National Institute on Drug Abuse (NIDA), FDA acts as the lead agency within HHS in carrying out the Assistant Secretary’s scheduling responsibilities under the CSA, with the concurrence of NIDA. 50 FR 9518, Mar. 8, 1985. PO 00000 Frm 00001 Fmt 4702 Sfmt 4702 this notification shall be taken into consideration before a final order is published. 21 U.S.C. 811(h)(4). To make a finding that placing a substance temporarily into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety, the Deputy Administrator is required to consider three of the eight factors set forth in section 201(c) of the CSA, 21 U.S.C. 811(c): The substance’s history and current pattern of abuse; the scope, duration and significance of abuse; and what, if any, risk there is to the public health. 21 U.S.C. 811(c)(4)–(6). Consideration of these factors includes actual abuse, diversion from legitimate channels, and clandestine importation, manufacture, or distribution. 21 U.S.C. 811(h)(3). A substance meeting the statutory requirements for temporary scheduling may only be placed in Schedule I. 21 U.S.C. 811(h)(1). Substances in Schedule I are those that have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. 21 U.S.C. 812(b)(1). Available data and information for 25INBOMe, 25C-NBOMe, and 25B-NBOMe indicate that these three synthetic phenethylamines have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Synthetic Phenethylamines The 2-methoxybenzyl series of 2C phenethylamine substances, such as 25I-NBOMe, 25C-NBOMe, and 25BNBOMe, has been developed over the last 10 years for use in mapping and investigating the serotonin receptors in the mammalian brain. 25I-NBOMe and 25B-NBOMe were first described by legitimate research laboratories in 2003. Subsequent studies involving these two substances appeared in the scientific literature starting in 2006. 25C-NBOMe first appeared in the scientific literature in 2011. No approved medical use has been identified for these synthetic phenethylamines, nor have they been approved by the FDA for human consumption. Synthetic 2C phenethylamine substances, of which 25I-NBOMe, 25C-NBOMe, and 25BNBOMe are representative, are sotermed for the two-carbon ethylene E:\FR\FM\10OCP1.SGM 10OCP1 61992 Federal Register / Vol. 78, No. 197 / Thursday, October 10, 2013 / Proposed Rules pmangrum on DSK3VPTVN1PROD with PROPOSALS group between the phenyl ring and the amino group of the phenethylamine and are substituted with methoxy groups at the 2 and 5 positions of the phenyl ring. Numerous blotter papers and food items have been analyzed, and combinations of one or more of 25I-NBOMe, 25CNBOMe, and 25B-NBOMe have been identified as adulterants. Bulk quantities of these substances have been encountered as powders and liquid solutions. From November 2011 through June 2013, according to the System to Retrieve Information from Drug Evidence 2 (STRIDE) data, there are 54 exhibits involving 27 cases for 25INBOMe; 27 exhibits involving 12 cases for 25C-NBOMe; and 3 exhibits involving 3 cases for 25B-NBOMe. From June 2011 through March 2013, the National Forensic Laboratory Information System 3 (NFLIS) registered 689 reports containing these synthetic phenethylamines (25I-NBOMe-582 reports; 25C-NBOMe-94 reports; 25BNBOMe-13 reports) across 33 states. No instances involving 25I-NBOMe, 25CNBOMe, or 25B-NBOMe were reported in NFLIS prior to June 2011. Factor 4. History and Current Pattern of Abuse One or more 2-methoxybenzyl analogues of the 2C compounds described here have been available over the Internet since 2010. The first identified domestic law enforcement encounter with 25I-NBOMe occurred in June 2011 in Milwaukee, Wisconsin. Information from published studies and law enforcement reports, supplemented with discussions on Internet Web sites and personal communications, document abuse of 25I-NBOMe, 25C-NBOMe, and 25BNBOMe by nasal insufflation of powders, intravenous injection or nasal absorption of liquid solutions, sublingual or buccal administration of blotter papers, and consumption of food items laced with these substances. These sources also report that 25INBOMe, 25C-NBOMe, and 25B-NBOMe are often purported to be Schedule I hallucinogens like lysergic acid diethylamide (LSD). Reports document that the abuse of these substances can cause severe toxic reactions, including death. According to United States Customs and Border Protection data, bulk quantities of powdered 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe have 2 STRIDE includes data on analyzed samples from DEA laboratories. 3 NFLIS is a database that collects scientifically verified data on analyzed samples in state and local forensic laboratories. VerDate Mar<15>2010 12:03 Oct 09, 2013 Jkt 232001 been seized from shipments originating overseas, particularly from Asia. Given the relatively small quantity of these substances predicted to produce a hallucinogenic effect in humans, single seizures of these substances are capable of producing hundreds of thousands to millions of dosage units. Large seizures of these substances prepared on blotter papers have also been reported. Abuse of 25I-NBOMe, 25C-NBOMe, and 25BNBOMe has been characterized with acute public health and safety issues domestically and abroad. In response, a number of states and foreign governments have controlled these substances. Factor 5. Scope, Duration and Significance of Abuse According to forensic laboratory reports, the first law enforcement encounter with 25I-NBOMe in the United States occurred in June 2011. According to NFLIS, 689 exhibits involving 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe were submitted to forensic laboratories between June 2011 and March 2013 from a number of states including Alabama, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Iowa, Indiana, Illinois, Kansas, Kentucky, Louisiana, Maryland, Maine, Minnesota, Missouri, New Hampshire, New Jersey, New Mexico, North Dakota, Nebraska, Nevada, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Wisconsin, and Wyoming. The number of reports submitted to NFLIS involving 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe has increased in each of the last five quarters where data is available. According to STRIDE, there are 84 records that identify 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe in evidence submitted to DEA laboratories between November 2011 and June 2013. Factor 6. What, if Any, Risk There Is to the Public Health In 2012 and 2013, emergency department physicians and toxicologists published and presented numerous case reports of patients treated for exposure to 25I-NBOMe. The adverse health effects reported include tachycardia, hypertension, agitation, aggression, visual and auditory hallucinations, seizures, hyperpyrexia, clonus, elevated white cell count, elevated creatine kinase, metabolic acidosis, rhabdomyolysis, and acute kidney injury. Medical examiner and postmortem toxicology reports from 11 states implicate some combination of 25INBOMe, 25C-NBOMe, and 25B-NBOMe in the death of at least 14 individuals. PO 00000 Frm 00002 Fmt 4702 Sfmt 4702 These reports suggest that 11 individuals died of acute toxicity, and 3 individuals died of unpredictable or violent behavior due to 25I-NBOMe toxicity. 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe have each been detected in postmortem blood toxicology for cases of acute toxicity. Since abusers obtain these drugs through unknown sources, the identity, purity, and quantity of these substances is uncertain and inconsistent, thus posing significant adverse health risks to users. There are no recognized therapeutic uses of these substances in the United States and possible deadly drug interactions between 25I-NBOMe and FDA approved medications have been noted. Finding of Necessity of Schedule I Placement To Avoid Imminent Hazard to Public Safety Based on the above data and information, the continued uncontrolled manufacture, distribution, importation, exportation, and abuse of 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe pose an imminent hazard to the public safety. The DEA is not aware of any currently accepted medical uses for these synthetic phenethylamines in the United States. A substance meeting the statutory requirements for temporary scheduling, 21 U.S.C. 811(h)(1), may only be placed in Schedule I. Substances in Schedule I are those that have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Available data and information for 25I-NBOMe, 25CNBOMe, and 25B-NBOMe indicate that these three synthetic phenethylamines have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. As required by section 201(h)(4) of the CSA, 21 U.S.C. 811(h), the Deputy Administrator through a letter dated September 3, 2013, notified the Assistant Secretary of the intention to temporarily place these three synthetic phenethylamines in Schedule I. Conclusion This notice of intent initiates an expedited temporary scheduling action and provides the 30-day notice pursuant to section 201(h) of the CSA, 21 U.S.C. 811(h). In accordance with the provisions of section 201(h) of the CSA, 21 U.S.C. 811(h), the Deputy Administrator considered available data and information, herein set forth the grounds for his determination that it is E:\FR\FM\10OCP1.SGM 10OCP1 pmangrum on DSK3VPTVN1PROD with PROPOSALS Federal Register / Vol. 78, No. 197 / Thursday, October 10, 2013 / Proposed Rules necessary to temporarily schedule three synthetic phenethylamines, 2-(4-iodo2,5-dimethoxyphenyl)-N-(2methoxybenzyl)ethanamine (25INBOMe; 2C-I-NBOMe; 25I; Cimbi-5), 2(4-chloro-2,5-dimethoxyphenyl)-N-(2methoxybenzyl)ethanamine (25CNBOMe; 2C-C-NBOMe; 25C; Cimbi-82) and 2-(4-bromo-2,5-dimethoxyphenyl)N-(2-methoxybenzyl)ethanamine (25BNBOMe; 2C-B-NBOMe; 25B; Cimbi-36), in Schedule I of the CSA, and finds that placement of these synthetic phenethylamines into Schedule I of the CSA is warranted in order to avoid an imminent hazard to the public safety. Because the Deputy Administrator hereby finds that it is necessary to temporarily place these synthetic phenethylamines into Schedule I to avoid an imminent hazard to the public safety, any subsequent final order temporarily scheduling these substances will be effective on the date of publication in the Federal Register, and will be in effect for a period of two years, with a possible extension of one additional year, pending completion of the permanent or regular scheduling process. 21 U.S.C. 811(h)(1) and (2). It is the intention of the Deputy Administrator to issue such a final order as soon as possible after the expiration of 30 days from the date of publication of this notice. 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe will then be subject to the regulatory controls and administrative, civil, and criminal sanctions applicable to the manufacture, distribution, possession, importation, exportation, research, and conduct of instructional activities of a Schedule I controlled substance under the CSA. The CSA sets forth specific criteria for scheduling a drug or other substance. Regular scheduling actions in accordance with 21 U.S.C. 811(a) are subject to formal rulemaking procedures done ‘‘on the record after opportunity for a hearing’’ conducted pursuant to the provisions of 5 U.S.C. 556 and 557. 21 U.S.C. 811. The regular scheduling process of formal rulemaking affords interested parties with appropriate process and the government with any additional relevant information needed to make a determination. Final decisions that conclude the regular scheduling process of formal rulemaking are subject to judicial review. 21 U.S.C. 877. Temporary scheduling orders are not subject to judicial review. 21 U.S.C. 811(h)(6). Regulatory Matters Section 201(h) of the CSA, 21 U.S.C. 811(h), provides for an expedited temporary scheduling action where VerDate Mar<15>2010 12:03 Oct 09, 2013 Jkt 232001 such action is necessary to avoid an imminent hazard to the public safety. As provided in this subsection, the Attorney General may, by order, schedule a substance in Schedule I on a temporary basis. Such an order may not be issued before the expiration of 30 days from (1) the publication of a notice in the Federal Register of the intention to issue such order and the grounds upon which such order is to be issued, and (2) the date that notice of a proposed temporary scheduling order is transmitted to the Assistant Secretary of HHS. 21 U.S.C. 811(h)(1). Inasmuch as section 201(h) of the CSA directs that temporary scheduling actions be issued by order and sets forth the procedures by which such orders are to be issued, the DEA believes that the notice and comment requirements of section 553 of the Administrative Procedure Act (APA), 5 U.S.C. 553, do not apply to this notice of intent. In the alternative, even assuming that this notice of intent might be subject to section 553 of the APA, the Deputy Administrator finds that there is good cause to forgo the notice and comment requirements of section 553, as any further delays in the process for issuance of temporary scheduling orders would be impracticable and contrary to the public interest in view of the manifest urgency to avoid an imminent hazard to the public safety. Although the DEA believes this notice of intent to issue a temporary scheduling order is not subject to the notice and comment requirements of section 553 of the APA, the DEA notes that in accordance with 21 U.S.C. 811(h)(4), the Deputy Administrator will be taking into consideration any comments submitted by the Assistant Secretary with regard to the proposed temporary scheduling order. Further, the DEA believes that this temporary scheduling action is not a ‘‘rule’’ as defined by 5 U.S.C. 601(2), and, accordingly, is not subject to the requirements of the Regulatory Flexibility Act (RFA). The requirements for the preparation of an initial regulatory flexibility analysis in 5 U.S.C. 603(a) are not applicable where, as here, the DEA is not required by section 553 of the APA or any other law to publish a general notice of proposed rulemaking. Additionally, this action is not a significant regulatory action as defined by Executive Order 12866 (Regulatory Planning and Review), section 3(f), and, accordingly, this action has not been reviewed by the Office of Management and Budget (OMB). PO 00000 Frm 00003 Fmt 4702 Sfmt 9990 61993 This action will not have substantial direct effects on the States, on the relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government. Therefore, in accordance with Executive Order 13132 (Federalism) it is determined that this action does not have sufficient federalism implications to warrant the preparation of a Federalism Assessment. List of Subjects in 21 CFR Part 1308 Administrative practice and procedure, Drug traffic control, Reporting and recordkeeping requirements. Under the authority vested in the Attorney General by section 201(h) of the CSA, 21 U.S.C. 811(h), and delegated to the Deputy Administrator of the DEA by Department of Justice regulations (28 CFR 0.100, Appendix to Subpart R), the Deputy Administrator hereby intends to order that 21 CFR Part 1308 be amended as follows: PART 1308—SCHEDULES OF CONTROLLED SUBSTANCES 1. The authority citation for Part 1308 continues to read as follows: ■ Authority: 21 U.S.C. 811, 812, 871(b), unless otherwise noted. 2. Section 1308.11 is amended by adding new paragraphs (h)(12), (13), and (14) to read as follows: ■ § 1308.11 Schedule I. * * * * * (h) * * * (12) 2-(4-iodo-2,5-dimethoxyphenyl)N-(2-methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts and salts of isomers— 7538 (Other names: 25I-NBOMe; 2C-INBOMe; 25I; Cimbi-5) (13) 2-(4-chloro-2,5dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine, its optical, positional, and geometric isomers, salts and salts of isomers—7537 (Other names: 25CNBOMe; 2C-C-NBOMe; 25C; Cimbi-82) (14) 2-(4-bromo-2,5dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine, its optical, positional, and geometric isomers, salts and salts of isomers—7536 (Other names: 25BNBOMe; 2C-B-NBOMe; 25B; Cimbi-36) Dated: October 4, 2013. Thomas M. Harrigan, Deputy Administrator. [FR Doc. 2013–24432 Filed 10–9–13; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\10OCP1.SGM 10OCP1
[Federal Register Volume 78, Number 197 (Thursday, October 10, 2013)]
[Proposed Rules]
This section of the FEDERAL REGISTER contains notices to the public of
the proposed issuance of rules and regulations. The purpose of these
notices is to give interested persons an opportunity to participate in
the rule making prior to the adoption of the final rules.
Federal Register / Vol. 78, No. 197 / Thursday, October 10, 2013 /
21 CFR Part 1308
[Docket No. DEA-382]
Schedules of Controlled Substances: Temporary Placement of Three
Synthetic Phenethylamines Into Schedule I
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Notice of Intent.
SUMMARY: The Deputy Administrator of the Drug Enforcement
Administration (DEA) is issuing this notice of intent to temporarily
schedule three synthetic phenethylamines into the Controlled Substances
Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C.
811(h). The substances are 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5), 2-(4-
chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe;
2C-C-NBOMe; 25C; Cimbi-82), and 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)
[hereinafter 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe]. This action is based
on a finding by the Deputy Administrator that the placement of these
synthetic phenethylamines into Schedule I of the CSA is necessary to
avoid an imminent hazard to the public safety. Any final order will be
published in the Federal Register and may not be issued prior to
November 12, 2013. Any final order will impose the administrative,
civil, and criminal sanctions and regulatory controls applicable to
Schedule I substances under the CSA on the manufacture, distribution,
possession, importation, exportation, research, and conduct of
instructional activities of these synthetic phenethylamines.
FOR FURTHER INFORMATION CONTACT: Ruth A. Carter, Chief, Policy
Evaluation and Analysis Section, Office of Diversion Control, Drug
Enforcement Administration; Mailing Address: 8701 Morrissette Drive,
Springfield, Virginia 22152, Telephone (202) 598-6812.
Section 201 of the CSA, 21 U.S.C. 811, provides the Attorney
General with the authority to temporarily place a substance into
Schedule I of the CSA for two years without regard to the requirements
of 21 U.S.C. 811(b) if he finds that such action is necessary to avoid
imminent hazard to the public safety. 21 U.S.C. 811(h). In addition, if
proceedings to control a substance are initiated under 21 U.S.C.
811(a)(1), the Attorney General may extend the temporary scheduling for
up to one year. 21 U.S.C. 811(h)(2).
Where the necessary findings are made, a substance may be
temporarily scheduled if it is not listed in any other schedule under
section 202 of the CSA, 21 U.S.C. 812, or if there is no exemption or
approval in effect under section 505 of the Federal Food, Drug, and
Cosmetic Act (FD&C Act), 21 U.S.C. 355, for the substance. 21 U.S.C.
811(h)(1). The Attorney General has delegated his authority under 21
U.S.C. 811 to the Administrator of the DEA, who in turn has delegated
her authority to the Deputy Administrator of the DEA. 28 CFR 0.100,
0.104.
Section 201(h)(4) of the CSA, 21 U.S.C. 811(h)(4), requires the
Deputy Administrator to notify the Secretary of the Department of
Health and Human Services (HHS) of his intention to temporarily place a
substance into Schedule I of the CSA.\1\ As 25I-NBOMe, 25C-NBOMe, and
25B-NBOMe are not currently listed in any schedule under the CSA, the
DEA believes that the conditions of 21 U.S.C. 811(h)(1) have been
satisfied. Any comments submitted by the Assistant Secretary in
response to this notification shall be taken into consideration before
a final order is published. 21 U.S.C. 811(h)(4).
\1\ Because the Secretary of the HHS has delegated to the
Assistant Secretary for Health of the HHS the authority to make
domestic drug scheduling recommendations, for purposes of this
Notice of Intent, all subsequent references to ``Secretary'' have
been replaced with ``Assistant Secretary.'' As set forth in a
memorandum of understanding entered into by HHS, the Food and Drug
Administration (FDA), and the National Institute on Drug Abuse
(NIDA), FDA acts as the lead agency within HHS in carrying out the
Assistant Secretary's scheduling responsibilities under the CSA,
with the concurrence of NIDA. 50 FR 9518, Mar. 8, 1985.
To make a finding that placing a substance temporarily into
Schedule I of the CSA is necessary to avoid an imminent hazard to the
public safety, the Deputy Administrator is required to consider three
of the eight factors set forth in section 201(c) of the CSA, 21 U.S.C.
811(c): The substance's history and current pattern of abuse; the
scope, duration and significance of abuse; and what, if any, risk there
is to the public health. 21 U.S.C. 811(c)(4)-(6). Consideration of
these factors includes actual abuse, diversion from legitimate
channels, and clandestine importation, manufacture, or distribution. 21
U.S.C. 811(h)(3).
A substance meeting the statutory requirements for temporary
scheduling may only be placed in Schedule I. 21 U.S.C. 811(h)(1).
Substances in Schedule I are those that have a high potential for
abuse, no currently accepted medical use in treatment in the United
States, and a lack of accepted safety for use under medical
supervision. 21 U.S.C. 812(b)(1). Available data and information for
25I-NBOMe, 25C-NBOMe, and 25B-NBOMe indicate that these three synthetic
phenethylamines have a high potential for abuse, no currently accepted
medical use in treatment in the United States, and a lack of accepted
safety for use under medical supervision.
Synthetic Phenethylamines
The 2-methoxybenzyl series of 2C phenethylamine substances, such as
25I-NBOMe, 25C-NBOMe, and 25B-NBOMe, has been developed over the last
10 years for use in mapping and investigating the serotonin receptors
in the mammalian brain. 25I-NBOMe and 25B-NBOMe were first described by
legitimate research laboratories in 2003. Subsequent studies involving
these two substances appeared in the scientific literature starting in
2006. 25C-NBOMe first appeared in the scientific literature in 2011. No
approved medical use has been identified for these synthetic
phenethylamines, nor have they been approved by the FDA for human
consumption. Synthetic 2C phenethylamine substances, of which 25I-
NBOMe, 25C-NBOMe, and 25B-NBOMe are representative, are so-termed for
the two-carbon ethylene
group between the phenyl ring and the amino group of the phenethylamine
and are substituted with methoxy groups at the 2 and 5 positions of the
phenyl ring. Numerous blotter papers and food items have been analyzed,
and combinations of one or more of 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe
have been identified as adulterants. Bulk quantities of these
substances have been encountered as powders and liquid solutions.
From November 2011 through June 2013, according to the System to
Retrieve Information from Drug Evidence \2\ (STRIDE) data, there are 54
exhibits involving 27 cases for 25I-NBOMe; 27 exhibits involving 12
cases for 25C-NBOMe; and 3 exhibits involving 3 cases for 25B-NBOMe.
From June 2011 through March 2013, the National Forensic Laboratory
Information System \3\ (NFLIS) registered 689 reports containing these
synthetic phenethylamines (25I-NBOMe-582 reports; 25C-NBOMe-94 reports;
25B-NBOMe-13 reports) across 33 states. No instances involving 25I-
NBOMe, 25C-NBOMe, or 25B-NBOMe were reported in NFLIS prior to June
\2\ STRIDE includes data on analyzed samples from DEA
laboratories.
\3\ NFLIS is a database that collects scientifically verified
data on analyzed samples in state and local forensic laboratories.
Factor 4. History and Current Pattern of Abuse
One or more 2-methoxybenzyl analogues of the 2C compounds described
here have been available over the Internet since 2010. The first
identified domestic law enforcement encounter with 25I-NBOMe occurred
in June 2011 in Milwaukee, Wisconsin.
Information from published studies and law enforcement reports,
supplemented with discussions on Internet Web sites and personal
communications, document abuse of 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe
by nasal insufflation of powders, intravenous injection or nasal
absorption of liquid solutions, sublingual or buccal administration of
blotter papers, and consumption of food items laced with these
substances. These sources also report that 25I-NBOMe, 25C-NBOMe, and
25B-NBOMe are often purported to be Schedule I hallucinogens like
lysergic acid diethylamide (LSD). Reports document that the abuse of
these substances can cause severe toxic reactions, including death.
According to United States Customs and Border Protection data, bulk
quantities of powdered 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe have been
seized from shipments originating overseas, particularly from Asia.
Given the relatively small quantity of these substances predicted to
produce a hallucinogenic effect in humans, single seizures of these
substances are capable of producing hundreds of thousands to millions
of dosage units. Large seizures of these substances prepared on blotter
papers have also been reported. Abuse of 25I-NBOMe, 25C-NBOMe, and 25B-
NBOMe has been characterized with acute public health and safety issues
domestically and abroad. In response, a number of states and foreign
governments have controlled these substances.
Factor 5. Scope, Duration and Significance of Abuse
According to forensic laboratory reports, the first law enforcement
encounter with 25I-NBOMe in the United States occurred in June 2011.
According to NFLIS, 689 exhibits involving 25I-NBOMe, 25C-NBOMe, and
25B-NBOMe were submitted to forensic laboratories between June 2011 and
March 2013 from a number of states including Alabama, Arkansas,
California, Colorado, Connecticut, Florida, Georgia, Iowa, Indiana,
Illinois, Kansas, Kentucky, Louisiana, Maryland, Maine, Minnesota,
Missouri, New Hampshire, New Jersey, New Mexico, North Dakota,
Nebraska, Nevada, Ohio, Oklahoma, Pennsylvania, South Carolina,
Tennessee, Texas, Utah, Virginia, Wisconsin, and Wyoming. The number of
reports submitted to NFLIS involving 25I-NBOMe, 25C-NBOMe, and 25B-
NBOMe has increased in each of the last five quarters where data is
available. According to STRIDE, there are 84 records that identify 25I-
NBOMe, 25C-NBOMe, and 25B-NBOMe in evidence submitted to DEA
laboratories between November 2011 and June 2013.
Factor 6. What, if Any, Risk There Is to the Public Health
In 2012 and 2013, emergency department physicians and toxicologists
published and presented numerous case reports of patients treated for
exposure to 25I-NBOMe. The adverse health effects reported include
tachycardia, hypertension, agitation, aggression, visual and auditory
hallucinations, seizures, hyperpyrexia, clonus, elevated white cell
count, elevated creatine kinase, metabolic acidosis, rhabdomyolysis,
and acute kidney injury.
Medical examiner and postmortem toxicology reports from 11 states
implicate some combination of 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe in
the death of at least 14 individuals. These reports suggest that 11
individuals died of acute toxicity, and 3 individuals died of
unpredictable or violent behavior due to 25I-NBOMe toxicity. 25I-NBOMe,
25C-NBOMe, and 25B-NBOMe have each been detected in postmortem blood
toxicology for cases of acute toxicity.
Since abusers obtain these drugs through unknown sources, the
identity, purity, and quantity of these substances is uncertain and
inconsistent, thus posing significant adverse health risks to users.
There are no recognized therapeutic uses of these substances in the
United States and possible deadly drug interactions between 25I-NBOMe
and FDA approved medications have been noted.
Finding of Necessity of Schedule I Placement To Avoid Imminent Hazard
to Public Safety
Based on the above data and information, the continued uncontrolled
manufacture, distribution, importation, exportation, and abuse of 25I-
NBOMe, 25C-NBOMe, and 25B-NBOMe pose an imminent hazard to the public
safety. The DEA is not aware of any currently accepted medical uses for
these synthetic phenethylamines in the United States. A substance
meeting the statutory requirements for temporary scheduling, 21 U.S.C.
811(h)(1), may only be placed in Schedule I. Substances in Schedule I
are those that have a high potential for abuse, no currently accepted
safety for use under medical supervision. Available data and
information for 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe indicate that these
three synthetic phenethylamines have a high potential for abuse, no
currently accepted medical use in treatment in the United States, and a
lack of accepted safety for use under medical supervision. As required
by section 201(h)(4) of the CSA, 21 U.S.C. 811(h), the Deputy
Administrator through a letter dated September 3, 2013, notified the
Assistant Secretary of the intention to temporarily place these three
synthetic phenethylamines in Schedule I.
This notice of intent initiates an expedited temporary scheduling
action and provides the 30-day notice pursuant to section 201(h) of the
CSA, 21 U.S.C. 811(h). In accordance with the provisions of section
201(h) of the CSA, 21 U.S.C. 811(h), the Deputy Administrator
considered available data and information, herein set forth the grounds
for his determination that it is
necessary to temporarily schedule three synthetic phenethylamines, 2-
(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe;
2C-I-NBOMe; 25I; Cimbi-5), 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) and 2-
(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe;
2C-B-NBOMe; 25B; Cimbi-36), in Schedule I of the CSA, and finds that
placement of these synthetic phenethylamines into Schedule I of the CSA
is warranted in order to avoid an imminent hazard to the public safety.
Because the Deputy Administrator hereby finds that it is necessary
to temporarily place these synthetic phenethylamines into Schedule I to
avoid an imminent hazard to the public safety, any subsequent final
order temporarily scheduling these substances will be effective on the
date of publication in the Federal Register, and will be in effect for
a period of two years, with a possible extension of one additional
year, pending completion of the permanent or regular scheduling
process. 21 U.S.C. 811(h)(1) and (2). It is the intention of the Deputy
Administrator to issue such a final order as soon as possible after the
expiration of 30 days from the date of publication of this notice. 25I-
NBOMe, 25C-NBOMe, and 25B-NBOMe will then be subject to the regulatory
controls and administrative, civil, and criminal sanctions applicable
to the manufacture, distribution, possession, importation, exportation,
research, and conduct of instructional activities of a Schedule I
controlled substance under the CSA.
The CSA sets forth specific criteria for scheduling a drug or other
substance. Regular scheduling actions in accordance with 21 U.S.C.
811(a) are subject to formal rulemaking procedures done ``on the record
after opportunity for a hearing'' conducted pursuant to the provisions
of 5 U.S.C. 556 and 557. 21 U.S.C. 811. The regular scheduling process
of formal rulemaking affords interested parties with appropriate
process and the government with any additional relevant information
needed to make a determination. Final decisions that conclude the
regular scheduling process of formal rulemaking are subject to judicial
review. 21 U.S.C. 877. Temporary scheduling orders are not subject to
judicial review. 21 U.S.C. 811(h)(6).
Section 201(h) of the CSA, 21 U.S.C. 811(h), provides for an
expedited temporary scheduling action where such action is necessary to
avoid an imminent hazard to the public safety. As provided in this
subsection, the Attorney General may, by order, schedule a substance in
Schedule I on a temporary basis. Such an order may not be issued before
the expiration of 30 days from (1) the publication of a notice in the
Federal Register of the intention to issue such order and the grounds
upon which such order is to be issued, and (2) the date that notice of
a proposed temporary scheduling order is transmitted to the Assistant
Secretary of HHS. 21 U.S.C. 811(h)(1).
Inasmuch as section 201(h) of the CSA directs that temporary
scheduling actions be issued by order and sets forth the procedures by
which such orders are to be issued, the DEA believes that the notice
and comment requirements of section 553 of the Administrative Procedure
Act (APA), 5 U.S.C. 553, do not apply to this notice of intent. In the
alternative, even assuming that this notice of intent might be subject
to section 553 of the APA, the Deputy Administrator finds that there is
good cause to forgo the notice and comment requirements of section 553,
as any further delays in the process for issuance of temporary
scheduling orders would be impracticable and contrary to the public
interest in view of the manifest urgency to avoid an imminent hazard to
the public safety.
Although the DEA believes this notice of intent to issue a
temporary scheduling order is not subject to the notice and comment
requirements of section 553 of the APA, the DEA notes that in
accordance with 21 U.S.C. 811(h)(4), the Deputy Administrator will be
taking into consideration any comments submitted by the Assistant
Secretary with regard to the proposed temporary scheduling order.
Further, the DEA believes that this temporary scheduling action is
not a ``rule'' as defined by 5 U.S.C. 601(2), and, accordingly, is not
subject to the requirements of the Regulatory Flexibility Act (RFA).
The requirements for the preparation of an initial regulatory
flexibility analysis in 5 U.S.C. 603(a) are not applicable where, as
here, the DEA is not required by section 553 of the APA or any other
law to publish a general notice of proposed rulemaking.
Additionally, this action is not a significant regulatory action as
defined by Executive Order 12866 (Regulatory Planning and Review),
section 3(f), and, accordingly, this action has not been reviewed by
the Office of Management and Budget (OMB).
This action will not have substantial direct effects on the States,
on the relationship between the national government and the States, or
on the distribution of power and responsibilities among the various
levels of government. Therefore, in accordance with Executive Order
13132 (Federalism) it is determined that this action does not have
sufficient federalism implications to warrant the preparation of a
Federalism Assessment.
List of Subjects in 21 CFR Part 1308
Administrative practice and procedure, Drug traffic control,
Reporting and recordkeeping requirements.
Under the authority vested in the Attorney General by section
201(h) of the CSA, 21 U.S.C. 811(h), and delegated to the Deputy
Administrator of the DEA by Department of Justice regulations (28 CFR
0.100, Appendix to Subpart R), the Deputy Administrator hereby intends
to order that 21 CFR Part 1308 be amended as follows:
PART 1308--SCHEDULES OF CONTROLLED SUBSTANCES
1. The authority citation for Part 1308 continues to read as follows:
Authority: 21 U.S.C. 811, 812, 871(b), unless otherwise noted.
2. Section 1308.11 is amended by adding new paragraphs (h)(12), (13),
and (14) to read as follows:
Sec.  1308.11  Schedule I.
(h) * * *
(12) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
its optical, positional, and geometric isomers, salts and salts of
isomers--7538 (Other names: 25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)
(13) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine, its optical, positional, and geometric
isomers, salts and salts of isomers--7537 (Other names: 25C-NBOMe; 2C-
C-NBOMe; 25C; Cimbi-82)
(14) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
isomers--7536 (Other names: 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)
Dated: October 4, 2013.
Thomas M. Harrigan,
Deputy Administrator.


43.3% of adults in Michigan face elevated coronavirus risks
by The Center Square
Michael Samsky, Detroit Stock City
About 43.3 percent of Michigan adults are considered at risk of coronavirus complications due to age or pre-existing medical conditions, the 18th highest share among the 50 states, according to a study released March 17 by the website 24/7 Wall St.
The share of adults over age 60 out of the total at-risk adult population is 72.5 percent, the 24/7 Wall St. report said. The share of adults age 18 to 60 who are at risk is 17.3 percent.
The source of the data used in the study was the nonprofit policy group Kaiser Family Foundation. The number of fatalities related to coronavirus in the United States could eventually be as high as 1.7 million, according to the U.S. Centers for Disease Control and Prevention, although the vast majority of those infected will not endure serious ailments.
About 105.5 million American adults age 18 and older, or 41 percent, face an elevated risk of serious illness if they contract the COVID-19 virus, Wall St. 24/7 reports. And among those at-risk adults, 5.7 million lack health insurance, according to the analysis.
Stay on top of Detroit news and views. Sign up for our weekly issue newsletter delivered each Wednesday.
News Hits coronavirus Michigan COVID-19 health care
Steve Neavling
Michigan's coronavirus death toll reaches 60, with 564 new positive cases
by Steve Neavling | Mar 26, 2020
Courtesy Of The Office Of The Governor
Coronavirus outbreak to get much worse before it gets better, Michigan officials warn
Wayne County Sheriff's Office commander dies from coronavirus


Biography of Father Matvey Gudaitis
Born into a peasant family in Nendrin (Lithuania) in 1873. Graduated from Theological Seminary and was ordained in 1897. From 1912 he served at Nativity of the Blessed Virgin Mary parish in Yalta; from 1913, he was the parish administrator. From 1919, when the Whites were in power in Crimea, he worked as secretary of the Lithuanian colony and later served at St. Klemens Church in Sevastopol. Also engaged in the distribution to priests and laity of material assistance received from abroad through the Polish Red Cross. He also received material assistance from Bishop Neveu, but he himself was all the while desperately poor, which is evident later in the investigatory documents where he is noted as “emaciated.” December 26, 1935 – arrested in a case against Catholic clergy and laity (Frison et al.). July 28, 1936 – presented with the indictment – which he did not sign. March 11-17, 1937 – a closed trial at which he was sentenced under Articles 58-4 and 58-11 of the Criminal Code of the RSFSR to ten years in corrective labor camps with loss of rights for five years [Special Collegium, Supreme Ct., Crimean ASSR]. Sent to a camp (at age sixty-four). Fate thereafter unknown. Source: Sokolovskyi, pp. 54-55
Gudaitis, Matvey; Gudaĭtis, Matveĭ Matveevich
Nendrin (Lithuania); I︠A︡lta (Ukraine); Sevastopolʹ (Ukraine)
male; clergy and religious; fate unknown


CENTER STAGE(director: Nicholas Hytner; screenwriter: Carol Heikkinen; cinematographer: Geoffrey Simpson; editor: Tariq Anwar; cast: Amanda Schull (Jody), Zoe Saldana (Eva), Susan May Pratt (Maureen), Peter Gallagher (Jonathan Reeves), Donna Murphy (Juliette Simone), Debra Monk (Maureen’s manipulative mother), Sascha Radetsky (Charlie), Eion Bailey (Jim), Shakiem Evans (Erik), Ethan Stiefel (Cooper), Christine Dunham (Audition Teacher), Karen Shallo (Mother at Audition), Laura Hicks (Nervous Mother), Elizabeth Hubbard (Joan Miller), Ilia Kulik (Sergei), Julie Kent (Kathleen); Runtime: 113; Columbia Pictures; 2000)
“The aim of the film was to be entertaining, the art part it dumbed down for mass consumption.”
This is a backstage drama of talented young dance students trying to be somebody, knowing that only a handful of them will achieve success in their chosen field. They try out for a fictional American Ballet Academy in NYC, hoping to be chosen for a coveted spot in their prestigious workshop program. If successful, three females and three males will be chosen for a dancing spot in the elite American Ballet Company.
The story is bogged down with clichés and cardboard characters, while the ballet dancing is the thing of beauty in this film. Most of the dancers are professionals of the highest standards and it shows by their excellent performance. One of them, the film’s star, Cooper (Ethan Stiefel), is recognized by most in the field as the best in the world. The framework of the story is the same formula seen in almost every Hollywood sports film, as the art of dancing is only paid lip service to. In fact, if this film wasn’t about ballet dancers, it could have been about chorus dancers or football players, and the same trite tale could have been woven. Which shows you how much art mattered. The best reason for seeing the film is that the dancing is alive and pulsating, choreographed by the likes of Balanchine, Susan Stroman and Christopher Wheeldon, as well as Ivanov and MacMillan. But if you want to see a quality ballet film with a real love story and with the pangs of what it means to be an artist, then your best bet is “The Red Shoes(48).”
The story follows a group of these young ballet students emphasizing their aspirations, their emotional problems, and their athletic stamina to take the rigors of their difficult work. The film is hip to ballet dancers, letting us in on the secret that many of the male dancers are gay and that a straight dancer is much welcomed by the ladies. Many of the dancers smoke a lot in the hopes of killing their appetite, as weight is something they are all concerned about. And, the film makes a point of showing how it becomes apparent that they can be easily devastated by criticism. They also gossip a lot, as well as compete hard to get a starring role, and are unduly jealous of another’s success.
All the film characters are made of stock types: the tough teacher who really cares; the unsophisticated who experiences rejection in love and harsh criticism from her teacher, but overcomes these embarrassments; the overeater who gets bounced from the academy for lack of self-control; the surly rebel who learns that it is sometimes necessary to conform; and, the bulimic with the pushy mother, who confronts her mother at last. It is was too much effort to be following all their predictable stories, especially when you know everything is going to be tied up in a nice pink ribbon by the end.
The main story deals with a nervously driven student and the best dancer in the world, and how they relate to each other. Jody (Amanda) is the dancing student whose parents would rather she were a freshman in college than dancing in NYC, and can’t share the joy she has in being accepted to the ABA. Cooper is the star of the ballet company whose ballerina girlfriend Kathleen married Jonathan (Peter Gallagher), the company’s head. On the rebound, he picks up the pretty but insecure Jody and takes advantage of her by taking her to bed and then fluffing her off. But he also gives her a big break and puts her into the new radical ballet he is creating as the guest choreographer for the students’ illustrious final exam, a workshop performance before a live audience. This gives her a chance to be recognized by all the directors of the major professional ballet troupes attending the performance.
The minor stories were about Sergei (Ilia Kulik, real-life Russian figure skater), a Russian dancer separated by distance from his ballerina girlfriend, who out of loneliness picks up a girl in a disco spot by saying he is in the Russian Mafia because when he tells other girls he meets that he’s in the ballet, they only laugh at him. Sascha Radetsky is Charlie, the engaging student dancer from the West Coast, who is the nice boy Jody eventually becomes involved with. Zoe Saldana is Eva Rodriguez, a black Hispanic with an attitude problem, who is a great dancer but must learn obedience. Eva sasses her teacher (Donna Murphy), comes late to class, chews gum in class, but loves to dance. And then there is Maureen (Pratt), who has been pushed into dance by her overbearing mother. Maureen is considered by the company to have the best technique but no heart in her dancing. Maureen reluctantly meets a college student studying medicine and goes against her mother’s wishes by dating him.
This film reminded me a lot of Hollywood’s ode to lowbrow culture “Band Wagon,” which was much more entertaining and had a much superior script.
In Center Stage there was plenty of dancing at rehearsals and it had two big ballet numbers. The aim of the film was to be entertaining, the art part it dumbed down for mass consumption. What it comes down to is that the soap opera story didn’t completely take away from the dance. Some sparkle could be detected in the eyes of the students when they were dancing.
24TH, THE
HIDEOUS KINKY